There
are a large number of myths and fairy tales about what causes ASD, and many
parents of children with the condition have spent many thousands of dollars
doing needless and sometimes harmful procedures in the faint hope that the
procedures will cure their child. It is clear, though, that they cause of
developmental delay in children is due to two or more deficiencies of the
children, whilst in the womb of a deficient mother. Thus, all children have been
found to be deficient in vitamin B2,
vitamin B12,
iron and/or
vitamin D. Despite this, people
with children with a child with autism appear to be desperate enough to try
anything, that has a vague, but non-proven chance of success. This is a very,
very costly non-solution to a basic biochemical deficiency. The
major problem with this way of thinking is that it has lead to the major
Paradigm of Autism Hence "There is no known cause of autism, it is a mixture of
environmental and genetic factors", AND "There is no known cure for autism" There is currently no
cure for autism. The corollary to the paradigm is that if there really is
cure for autism, then leading experts and governments are somehow unaware or it,
and hence if there is a major breakthrough in autism treatment it would be
International news and everyone would know of it. This can be exemplified by the
complete lack of Scientific effort currently underway by many large
organizations working in the field of Autism Research Viz: "XYZ does not focus
on curing autism, XYZ is more interested in research efforts that will support
people on the autism specturm and their families and carers to realize and reach
their goals and aspirations". Clearly there will have to be a massive paradigm
shift in organizations such as the aforementioned before, would possibly
countenance any new scientific research. Even then it is likely, that the
individuals involved within the hierarchy of such organizations will have to
maintain a status of "cognitive dissonance" in order to justify or validate
their previous paradigm. One of the major problems with the Paradigm is that it
becomes self-fullfilling in that no-one working on the cause of autism will get
public funding, which may explain why up until now significant advancements have
not been made in the field. This is despite literally $100 million being spent
on research see
Donate It is
the object of the current page to dispel some of the more common myths and
thereby help to "Save the children". The
Nemechek protocol, is a protocol that appears to be based on the concept that
ASD is caused by inflammation, which "can be seen" by the high levels of the
so-called inflammatory markers, KA/QA/HVA/VMA observed in autism. Hence the
protocol is based on treating putative bacterial inflammation in the gut, and
thereby reducing inflammation, which is postulated to also be occurring in the
brain and therefore hindering development. The protocol involves treating with
high dose fish oil, olive oil and inulin. The problem with the protocol is the
assumption that high levels of KA/QA/HVA/VMA are due to inflammation, however,
these are not inflammatory markers, they are markers of vitamin B12 deficiency
(see https://b12oils.com/b12.htm ).
There are claims that the protocol has some benefit in some children, however,
this could be explained by high levels of vitamin K in the olive oil, and also
the high levels of vitamin D in Cod-liver oil. The later could be of some
benefit as it is known that the majority of children with ASD are vitamin D
deficient see
https://b12oils.com/vitamind.htm .Normal fish oil does not contain
significant amounts of vitamin D. For
many years, there was a belief that conditions such as ASD and CFS were caused
by heavy metal contamination in the brain, and that people would not make
significant progress unless the metals were somehow removed from the brain. The
"offending" metal was postulated by Dr Cutler (a physicist who is now dead) to
be mercury. Hence the Cutler protocol was "invented". In the protocol, repeated
high doses of proposed chelating agents meso-demercaptosuccinic acid (DMSA),
dimercaptopropanesulfonic acid (DMPS) and ALA (alphalipoic acid, or thioctic
acid). Use of both DMSA and DMPS have been shown to be effective at chelation of
Arsenic and Lead following acute exposure, when the material is still
circulating in the blood, ie the first 24 hours, but after that it is
ineffective. Further, these two chelators are fairly non-specific and so whilst
they will chelate lead and arsenic, they also chelate and eliminate essential
metals such as chromium, cobalt copper and iron, which are used for physiologic
function. Further there is no known method of transport whereby DMA and/or DMPS
can actively target out some yet to be proven or identified deposit of mercury,
strip it off any neighbouring protein, and then use some yet to be identified
cellular expulsion method to selectively remove only the toxic metals without
removing other metals such as zinc, magnesium, calcium, copper, iron, etc.
Further, it is known that reagents such as DMSA and DMPS do not enter the brain.
The use of ALA is also controversial, hence the sulphur atoms in the structure
are disulfide linked and so are not available for chelation, or metal reduction.
ALA, is though, an essential co-factor in pyruvate dehydrogenase and in alpha-ketoglutarate
dehydrogenase, however, nearly half of the bodies ALA comes from the consumption
of meat. HMTA of children with ASD does not indicate levels of mercury any
higher than the average population. There has been no substantive evidence of
efficacy for the Cutler protocol. HMTA has though revealed many metal
deficiencies in ASD, including Calcium, Magnesium, Sodium, Potassium, and
critically Iodine, Selenium and Molybdenum. Side effects of the treatment
include vomiting, diarrhea, rash, low blood neutrophils. In a
similar fashion to the Cutler Chelation Therapy, there are those who believe
that heavy metals can be specifically removed by nanosized zeolite-like
molecules. In the Advanced Toxin Removal System (Advanced
TRS), clinoptilolite zeolite is nanosized and encased in water. The concept
being that somehow these tiny particles can travel where ever water can move and
magically source out some heavy metal toxin, and just as magically remove it
specifically from the body without removing any of the essential metals. This
approach is naive at best, and further, HMTA of children with autism does not
show any increased concentration of toxic metals over and above those in the
local atmosphere. Bentonite clay is also used orally, but as any person who
works with small molecules such as vitamins and minerals knows, this is totally
non-specific and will leave the recipient even more depleted in essential
vitamins and minerals.
There are a group of individuals "Anti-vaxxers" who believe that there is a
connection between vaccination and autism, and the concept has arisen that
children become vaccine injured, which then causes autism. One of the early
theories revolved around the use of thiomersal as a preservative in vaccines.
The use of thiomersal has now been discontinued, however the rate of vaccination
has risen from one in one thousand to now one in thirty-forty in the USA, over
the past 20 years, yet vaccination rates have remained the same. Potentially
vaccines, though, could, and should promote strong immune responses to the
vaccinating antigens. The generation of such immune responses is critically
dependent upon the activation of phagocytic cells, such as Macrophages. The
immune response would then consume large quantities of vitamin B2, iron, vitamin
B12 and vitamin D. Given that deficiencies in each of B2, B12, iron and vitamin
D have all been shown to be predisposing factors for the development of ASD, any
child who was "marginal" in these nutrients could have a negative response to
vaccine. For this reason, any person being vaccinated should ensure that they
receive adequate intake of vitamin B2 (plus Iodine, Selenium and Molybdenum),
vitamin B12, iron and vitamin D, at time of vaccination. This will ensure that
the child has a better immune response to the vaccination protocol. Many
of the children with ASD have been found to have elevated propionic acid, and
this has been postulated to cause the condition. Propionic acid
(CH3-CH2-COOH)(C3H6O2) is a normal metabolite of odd chain
fatty acids, and also can come from the deamination of Alanine
(CH3CH-NH2-COOH). In functional vitamin B2 deficiency, which every child with
ASD that we have
data for has, they cannot gain sufficient energy from fats or sugars and
so have to gain it from protein breakdown, and so metabolites of amino acids
start to appear in the urine, particularly if there are other deficiencies.
Normally, propionic acid is processed by the biotin-dependent enzyme Propionyl-CoA carboxylase, but in biotin deficiency, which most of the kids
have, particularly if they have been put on a diet low in eggs, they can't do
this and so elevated levels of propionic acid can be found. Generally this is
accompanied by elevated levels of methylcitrate in the Orgnic Acids Test. Hence
biotin replete, neurotypic individuals have methyl citrate of 0.6471 +/- 0.38,
whilst in ASD this is increased to 1.37 +/- 0.7724. Many ASD individuals have
levels much higher than this with data in the 2.0 to 5.0 not being uncommon. The
elevated Methylcitrate and propionic acid resolve upon treatment with 150-300 ug/day
biotin. "Propionic
acidemia is due to deficient activity of the enzyme propionyl-CoA carboxylase.
Because propionyl-CoA requires biotin as a cofactor, disorders of biotin also
cause propionic acidemia."
The ability of a cell to trap and retain folate is dependent upon
the addition of a polyglutamate tail on folate. This tail is "added" once folate
enters the folate cycle by the enzyme folylpolyglutamate synthetase (FPGS). In
methyl B12 deficiency dietary folate - which is primarily 5MTHF is not processed
by methionine synthase and so is not converted to Tetrahydrofolate, and so
cannot enter the folate cycle to be polyglutaminated. The result is that
intracellular folate levels are low, despite the observation that serum folate
levels may be high. This has lead to the concept of Cerebral Folate deficiency.
Yes, there is a deficiency of folate in most cells in the body, including the
brain, but this has arisen due the universal functional vitamin B12 deficiency,
observed in ASD.
Production of GABA, an inhibitory neurotransmitter in the body requires the
conversion of Glutamate to GABA by the enzyme Glutamic Acid Decarboxylase (GAD).
This enzyme requires the active form of vitamin B6, pyridoxal-phosphate as a
co-factor. Production of PLP, however, requires one of the two active forms of
vitamin B2, FMN. In deficiency of Iodine and/or Selenium, levels of FMN are
reduced, resulting in elevated glutamate and reduced GABA, with an altered
glutamate/GABA ratio. Treatment should consist of fixing the functional B2
deficiency. There is a "realm" of thought that the child should avoid glutamate.
Glutamate, though, is a non-essential amino acid, so the body will make it using
the aminotransferase of aspartate + a-Ketoglutatate ,<=> oxaloacetate +
glutamate, or Alanine + a-Keotglutarate <=> pyruvate + Glutamate. This basic bit
of biochemistry seems to have been missed by those who attempt to control
behavioural issues in children with autism, rather than fixing the
Iodine/Selenium deficiency, that causes the functional B2 deficiency (See
Pathway).(Sears et al, 2021; Yang
and Chang, 2014; Roja 2014). This increases the number of "mistreatments"
performed on children with autism, but those who do not understand basic
biochemistry. Interestingly, there are a higher number of mutations in GAD -
glutamate decarboxylase, in children with autism (data not publshed).
There is a popular theory put forwards by Dr Theoharides and others (Theoharides,
et al, 2016; 2013; Alam et al, 2017; Doeyas, 2018; Prata, et al, 2017; Al-Haddad
et al, 2019) that autism is caused by brain inflammation. Examination of
publications by these authors does not reveal any convincing data to support the
theory. Of note is that the elevated neurotransmitter metabolites, HVA, VMA, QA,
and KA that occur due to functional B12 deficiency, have often been cited as
inflammatory markers with little evidence to support that contention. Another crack-pot
theory from a Dr who should know better, Dr Richard Frye.
Following the concept that it is altered immune response in the brain that
causes autism, recently GcMAF therapy, which is designed to activate
macrophages, with the thought (or lack thereof) that this will overcome the
immune dysfunction in autism. The result appears to be similar to that seen in
Long COVID,
in which hyperferritinemia, typical of Macrophage Activation Syndrome (MAS)
(Rosario et al, 2013; Kernan and Carcillo, 2017), is observed and the
biochemical markers of vitamin B2 deficiency become elevated and markers of
functional iron deficiency such as lowered Haemoglobin, lower Haematocrit and
elevated citrate are observed. In addition functional B12 deficiency becomes
worse. This has resulted in the treated individuals actually getting worse,
which would also be expected considering, what happens in Long COVID, in which
there is extensive macrophage activation. This was not mentioned by the
company
There are many people who believe that autism is due to some genetic
predisposition. There is evidence that there are some mutations in those with
autism, however closer scrutiny reveals that the condition cannot be
predominantly of genetic origin. Hence the incidence of autism has increased
from around 1 in 1000, 25 year ago, the incidence has dramatically increased
over the past 25 years, and is now 1 to 30 (South Korea) 1 in 35 (in the US) and
around one in 40 in Australia (as of 2021). Clearly there is no genetic method
of increasing the incidence of a non-lethal mutation in the population by over
200-fold within one generation. Despite this obvious disconnect, many research
groups are still labouring to prove a genetic link for the condition. Despite
this, several groups are clinging to the concept that autism is due to mutations
in the MTHFR gene, and have even developed an
MTHFR gene mutation protocol. These protocols appear to be generated with
little knowledge of basic genetics by either those peddling the protocol or the
poor unsuspecting parent going through with the protocol. Hence, the incidence
of the common MTHFR gene mutation C665T by pure genetics should mean that the
population as a whole would be 25% "-/-", 50% "+/-", and 25% "-/-", however, due
to selection in low dietary folate and functional B2 deficiency, there is a
change of ratio in the normal population to 10% "-/-", 37% "+/-", and 40% "-/-".
This is almost identical to the observed frequency in the population with autism
8.5% "-/-", 43.6% "+/-", and 47.9% "-/-". Hence, the actual frequency of the
"+/+" allele is less in the population with autism, NOT, more. Initiation of
digestion involes an initial phase, the cephalic phase, in which histamine, is
secreted into the stomach and stimulates gastric motility and gastric emptying.
In Iodine/Selenium deficiency, there is reduced activation of vitamin B2 to FMN,
and that in turn results in reduced activation of vitamin B6 to P5P.This in turn
reduces the ability of the P5P-dependent enzyme, histidine decarboxylase to
convert histidine to histamine, with the result that there are problems with
that stimulation of gastric emptying and normal gastro-intestinal movement,
resulting in a condition called, Gastroeosophageal Reflux Disease. Many children with
autism suffer from
gastrointestinal (GI) symptoms, such as abdominal pain, chronic diarrhea,
constipation, vomiting, gastroesophageal reflux, intestinal infections, and
increased intestinal permeability (Bjørklund
et al, 2020)
Kamionkowski et al, 2022; Nath 2017; Lucarelli etal, 2017). Of these, GERD, is most likely caused by lack
of production of Histamine in the cephalic phase of digestion, which then does
not stimulate normal gastric emptying. Production of histamine occurs via the
action of the P5P-dependent enzyme, histidine decarboxylase, hence in children
that are deficient in Iodine, and/or Selenium, there will be reduced production
of histamine in the stomach, and hence gastric emptying will be compromised.
Unfortunately, due to poor understanding of the biochemistry of GERD, many
children are treated with PPIs, which will reduce the secretion of intrinsic
factor from the parietal cells in the stomach, and the reduced gastric acid
secretion will result in iron deficiency, as well as non-release of vitamin B12
from haptocorrin,. Hence B12 and iron deficiency will be worse. Vitamin B12
deficiency is a known associative factor following the long term use of PPIs. In functional B12
deficiency, there is poor maturation of the intestinal villi which then can
cause histamine intolerance due to lack of activity of the enzyme Diamino
Oxidase (DAO), and also sulphite intolerance due to lack of activity of the
Molybdenum dependent enzyme Sulphite oxidase (SUOX). This then means that the
children may experience a generalized food intolerance, specifically to high
histamine foods, or those with sulphite as a preservative. The Physician,
believing that these intolerances are due to allergies to the foods, will run an
food allergen test, looking for IgG antibodies to the food allergens. The
children will show a positive reaction to many foods that the child's eating,
and the child will be placed on a highly restrictive diet. This, response
appears to be due to lack of knowledge of the bodies response to food allergens.
It is very normal for all people to generate an IgG antibody response to
antigens from foods that we all eat. Generally the size of the antibody response
is proportional to the amount of the food that we eat. It is totally natural
response and the average person has a multitude of specific IgG antibodies.
These antibodies are generally protective and as such are not allergic
responses. IF an allergic response is suspected, the child should have a
traditional skin prick test with the suspected allergen (Russell-Jones etal,
1981, 1984),
Gluten-intolerance in the community is relatively rare with an
incidence of 0.1 to 1.0%. This intolerance is a feature of those with Coeliac
Disease, a condition that rapidly resolves upon removal of gluten. Patients with
Coeliac disease can present with gastrointestinal symptoms such as diarrhoea,
malabsorption and weight loss. The condition does not cause developmental delay.
The incidence of the disease has not changed appreciably over the
past 20 years, yet the incidence of ASD has increased from one in 1000 (less
than the rate of Celiac disease) to now one in 35 in the US. Confirmation of
Coeliac disease is performed by measuring anti-gliadin antibodies. Despite the
low incidence of Coeliac Disease the number of people who are now on Gluten-free
diets has increased to up to 25% in countries such as the UK, USA and Australia.
Many adults claim to "feel" better on a GF diet, and it appears to be the first
dietary change that physicians use on children with ASD. This has many
disadvantages, firstly, there is no need to avoid gluten-products if you do not
have Coeliac disease, but secondly, most commercial breads are now fortified
with folate, vitamin B1, and Iodine. This then means that a child who is placed
on a gluten-free diet can often suffer these deficiencies as can be seen in OAT
analysis and HMTA. Further, since one of the major sources of Gluten-free flour
is rice, the children can take in huge quantities of arsenic and lead, which
would be "Contra" in a person who is already having developmental issues that
would be further affected by lead and arsenic poisoning. Potentially, one of the
reasons that persons react to commercial breads, is not actually due to the
gluten, but rather to the sulphite used as a preservative in many foods.
Sulphite is normally converted to Sulphate in the body by a Molybdenum-dependent
enzyme, Sulphite Oxidase, and in Molybdenum deficiency persons get an
intolerance to sulphite, which then may lead to diarrhea, gut issues and
malabsorption. In house studies have shown that Molybdenum deficiency is very
common in children with ASD, with over 45 % of children with ASD having
Molybdenum deficiency via HMTA. Molybdenum deficiency is now so common in the
community that the range for Molybdenum in HMTA performed by Doctors Data has
shifted from 0.05-0.13 ppm in the 1990s, to now being out of range low 0.02-0.05
ppm in 2020, with over 70% of ASD individuals having Mo below 0.07 ppm.
Interestingly, although Coeliac disease does not cause developmental delay,
several studies have shown that sulphite is neurotoxic and in severe cases can
cause neonatal seizures, developmental delay, feeding difficulties,
microcephaly, brain atrophy and spasticity (Ergene etal, 2021; Grings etal,
2016; Veldman etal, 2010;
Jakubiczka-Smorag,etal 2016) and neuronal loss in the
hypocampus (Kocamaz
etal, 2012).
In individuals with a lack of vitamin B12, there is a reduced
production of melatonin, due to the lack of SAM to convert serotonin, either
produced in the gut or the brain, to melatonin. Gastro-intestinal problems are
common in individuals with low vitamin B12, and it is thought that melatonin has
a role to play in the maturation of the gut wall. Furthermore, low vitamin B12
is also associated with lack of activity of the enzyme histamine-N-methyl
transferase, an enzyme secreted in the gut wall that inactivates histamine, and
allows nutritionally normal people to consume foods with large amounts of
histamine in them. Since the allergic response to food allergens is the same as
that of histamine intolerance it is easy to assume that symptoms such as
flushing, urticarial, Rhinoconjunctivitis and rhinorrhea, Headaches,
and Digestive
tract disturbances: abdominal pain, diarrhea, nausea, vomiting are similar to
those from histamine intolerance, many parents assume that these types of
symptoms are caused by food allergy, and as such go on highly restrictive diets,
such as the GFCF diet. Somewhat illogically they assume that the ASD child will
then be cured. Early onset dairy intolerance/cow’s milk allergy is relatively
infrequent and occurs in around 2-7% of children, however, the allergy generally
resolves within a few years (Turck 2013; Denis etal, 2012). The incidence of
cow’s milk allergy was significantly lower in exclusively breast fed children
(Chandra and Hamad 1991).There is as yet no evidence that ASD is caused by
allergy to cow’s milk or that the use of a diet free of cow’s milk is of benefit
in treatment of individuals with ASD (Turck, 2013). In addition, lower intake of
milk has been associated with lower adolescent bone mineral density (Blanco etal,
2017). There are also no studies comparing the incidence of cow’s milk allergy
in normally developing children and those with autism spectrum disorder. The
presence of IgE antibodies in serum of individuals does not necessarily
correlate with allergic status, nor skin prick testing, but rather oral
challenge is more predictive of allergic status (Chauveau etal, 2016). Usually
cow’s milk can be re-introduced after 6 months of exclusion (Denis etal, 2012).
There are considerable logical problems with the adoption of the
GFCF diet.
The children are known to be
deficient in both vitamin B12 and vitamin B2, which arguably causes the
perceived symptomology.
Placing the children on GFCF
diets increases the level of B2 deficiency, and in countries which supplement
iodine into cows to produce iodized milk, the children then become iodine
deficient. The combined B2/Iodine deficiency causes an even greater deficiency
in vitamin B12.
Adopting the gluten free diet
adds further deficiencies to the mix as now the child becomes vitamin B1
deficient, and often selenium and molybdenum deficient.
Removing dairy from the diet
then causes calcium deficiency and extremely elevated levels of phosphoric acid
are present in the urine, reflecting stripping of the soluble calcium-phosphate
pool from the bone, and thereby reducing the bone density of the children.
It doesn’t cure autism, but it
can take a child who should have been treated with vitamin B2 and vitamin B12,
and makes them more B2 and B12 deficient and in addition makes them potentially
vitamin B1 deficient, Iodine, Selenium and molybdenum deficient and also calcium
deficient. The insult is further exacerbated if the child is also taken off
eggs, as this generally will make them biotin deficient.
Given that each of the
deficiencies can by themselves lead to demyelination of nerves, and given that
these deficiencies have also been associated with the development of dementia,
it seems almost inconceivable that such treatment is given to the children, yet
it is extremely common. A recent theory tries
to equate microplastics in the environment with increased incidence of autism in
males. The investigators did not look at metabolic biochemistry, nor could they
explain why the incidence is higher in males than females, nor how the
microplastics cause functional B2, and B12 deficiency, and measurable iron and
vitamin D deficiency
Rebutal This commonly held
belief is another myth. Once the nutritional deficiencies that over 99% of the
children with autism has, the nutritional deficiencies can be corrected, and if
done properly normal neurotypical development in the children can resume. Many
papers are emerging showing functional B12 deficiency as being the cause of
autism. Once this is fixed, development can continue.
The majority of children who have recently been diagnosed with
ASD have elevated B12, and as such are not deemed to be vitamin B12 deficient.
Hence there is the myth that vitamin B12 deficiency is NOT the cause of ASD.
Metabolic analysis using urinary Organic Acids (OAT) reveals that the children
are actually very deficient in both Adenosyl and particularly Methyl B12, which
is contrary to the elevated serum B12, as such the children have "Paradoxical B12 deficiency".
"Paradoxical B12 deficiency" is particularly common in ASD, CFS, PD and AD. Examples can be seen at
https://b12oils.com/b12.htm
Applied Behavioural Analysis Therapy, is the practice of applying
psychological principles of learning theory in a systematic way to modify
behaviour. Similar practice is carried out in dementia. Speech and Language
Therapy (SLT) is a similar practise. The people who practice
it, firstly charge a lot of money, but secondly, they have the belief (both in ASD and Dementia) that somehow you can over-come the metabolic deficiencies that
the people have by psychological principles. Given that it is the biochemical
deficits, particularly in the altered neuronal signalling, that causes the
behavioural and learning problems in ASD, it is not logical to assume that you
could "talk, or reason" the condition away. It would be about as effective as
talking to a raging bush-fire in order to get it to put itself out!!
Another "theory" of autism is that the children have Pediatric
autoimmune neuropthychiatric disorders, asssociated with streptoccal infections
(PANDAS). The theory is supposed to apply to a subset of children with OCD or
TIC disorders. Specifically the theory applies to Group A streptococci, an
extremely common pathogen in children, particularly those who repeatedly have
sore throats. The theory seems to piggy-back on conditions such as Post
Streptococcal nephritis and Post Streptococcal theumatic heart disease and Post
Streptococcal glomerulophritis. Of the many problems with the theory is that all
children with autism are biochemically the same. They all have functional B2
deficiency and functional B12 deficiency, which alone explains the condition.
Biofeedback involves trying to retrain the brain of children to function more
effectively. The problem with the technique is that it is the biochemical
deficiencies in the brain that are the reason for the poor performance of the
brains of the children. Fix the Biochemistry and then the children will perform
much better. The cost is $50-500 per session, depending upon the insurance cover
(which one would question) with 30-50 sessions required. Hence the cost would be
$1500 to $25,000. Little wonder that they try to push the technique!! to
Bioresonance is a classed as a Pseudoscience in which
Practitioners claim to be able to detect a variety of conditions, such as
autism, and treatment consists of treating autism without drugs by stimulating a
change of "bioresonance" in the body. Scientific evaluation has not shown
any advance
Fecal Transplants Several of the
neurotransmitters that control gut movement and maturation are also present in
the brain. The levels of these, particularly, melatonin and histamine, control
the movement and maturation of the gut. Whilst this is well known in the
literature, some "Health Practitioners" incorrectly assume that it is gut
bacteria that control these functions, and so needlessly put the children
through fecal transplants.
Transcranial Magnetic Stimulation
TMS is being trialed in an attempt to "help those who struggle with aspects
of having autism".
Upon questioning about how such stimulation can cure the
biochemical deficiencies in autism, the research groups were at a loss to
answer.
Bioresonance/Kerri Rivera
Bioresonance is a classed as a Pseudoscience in which
Practitioners claim to be able to detect a variety of conditions, such as
autism, and treatment consists of treating autism without drugs by stimulating a
change of "bioresonance" in the body. Scientific evaluation has not shown any
advance over and above the placebo effect. Once again the issue in Autism is the
deficiencies in vitamin B2 and vitamin B12. Such deficiencies cannot be changed
by electrical impulses such as are used in Bioresonance
Treatment Myths and BAD MEDICINE
Adrenenergic Agonists - such as Clonidine/Catapres. These are used to
boost the adrenalin response. Unfortunately the medical profession seems to have
missed the fact that the reason that ASD patients have less adrenalin is because
they are functionally deficient in vitamin B12 - MORE BAD MEDICINE. Of
course the drug comes with many side effects, including tiredness, lethargy,
fatigue, drowsiness, dry mouth, constipation.
Ritalin -
Methylphenidate creates a classic stimulant effect within the central nervous
system, mainly in the prefrontal cortex, by blocking the reuptake of the two
neurotransmitters norepinephrine and dopamine, thereby increasing the amount of
them in a key region of the brain associated with motivation and action. In most
cases, it improves ADHD symptoms such as hyperactivity and inattention. The
problem is that every child with ADHD is over-producing dopamine and
nor-adrenalin, due to functional B12 deficiency. Another case of
BAD MEDICINE.
Antihistamines -
The poor gut maturation means that the children are not producing the histamine
inactivating enzyme DAO, and so they react with histamines in food. Fix the gut
and they won't need the drugs. IN ADDITION, histamine is a powerful
neurotransmitter in the brain, so treatment with anti-histamines is contra in a
child who is trying to establish neuronal connections
Mestinon -
This drug is mistakenly given to the children, presumably due to their lack of
muscle tone, which is due to lack of iron and methylation. The drug has a huge
number of side-effects, including nausea, vomiting, diarrhoea, stomach cramps,
blurred vision, muscle cramps, twitching.
Another case of
BAD MEDICINE
GABA agonists -
Benzodiazapines- Valproate, Baclofen, - Production of GABA (one
third of neurons in the brain are GABA producing), requires the conversion of
glutamate to GABA by the P5P-dependent enzyme GAT. In I/Se deficiency,
riboflavin is not activated to FMN, and as a result vitamin B6 is not converted
to P5P, and so production of GABA is reduced. This will have huge consequences
as far as development of the brain is concerned where synaptogenesis depends
upon neurons firing and their firing being controlled. Further, lack of GABA
results in anxiety, fear, repetitive behaviours. increased auditory sensitivity
(Möhrle
etal, 2021; Huang etal, 2023)
and in severe cases, convulsions and epilepsy (10-30% of children with ASD;
Canitano, 2015). Unfortunately many health professionals treat these symptoms in
those with ASD with GABA agonists (Zhao
et al, 2022; Yang etal, 2021), rather than identifying the mineral deficiencies
that are causing the condition. In an attempt to over-come the lack of
production of GABA, the brain increases the uptake of glutamate - a
neurostimulant, which may also exacerbate the lack of inhibitory activity of
GABA, and thereby result in increased hyperactivity, It is also used to treat
Head Banging. Serum levels of glutamate
are increased in ASD, with the greater the severity corresponding to the greater
the increase (Cai etal 2016;
Khalifa etal, 2016).
It is therefore critically important to recognize and identify deficiencies in
Iodine and/or Selenium before the commencement of any heroic treatment such as
highly addictive GABA agonists. Further the use of these drugs can cause serious
side-effects such as drowsiness, impaired thinking, depression, anxiety,
impaired coordination, and vision problems, amongst others. Long term use of
Benzodiazepines have been shown to cause lower total brain volume, as well as
lower hippocampus, amygdala, and thalamus volume. They can also lead to
down-regulation of GABA receptors. This in a brain that is trying to form a
network of GABA neurons, that can control neuronal responses in the brain. In
this regard, GABA neurons normally compose around 30% of brain neurons.
Bumetanide,
a diuretic agent, is also used to enhance the effectiveness of GABA. Hence treatment of
autism with GABA agonists, without establishing cause is
Another case of
BAD MEDICINE
Stem cell therapy - Maturation of neuronal
stem cells into myelin- producing oligodendrocytes, requires that combined
action of the methylation product, melatonin, and the active form of vitamin D,
1,25-diOH-vitamin. The brains of children with autism are fully equipped with
stem cells, however, due to insufficient vitamin D and melatonin, they have not
been "turned on" to differentiate
Myths revisited
If one looks closely at all of the myths one is reminded of the witches in
Shakespeares play (Macbeth:
IV.i 10-19; 35-38), sitting around the cauldron chanting
" Double, double toil and trouble;
Fire burn and caldron bubble.
Fillet of a fenny snake,
In the caldron boil and bake;
Eye of newt and toe of frog,
Wool of bat and tongue of dog, Adder's fork and blind-worm's sting,
Lizard's leg and howlet's wing, etc
Ergene M, Yarar N, Öncel EP, Sezer T, Çavdarlı B, Ecevit İZ, Aydın Hİ. Severe
isolated sulfide oxidase deficiency with a novel mutation. Turk J Pediatr.
2021;63(4):716-720. doi: 10.24953/turkjped.2021.04.021. PMID: 34449156.
Grings M, Moura AP, Parmeggiani B, Motta MM, Boldrini RM, August PM, Matté C,
Wyse AT, Wajner M, Leipnitz G. Higher susceptibility of cerebral cortex and
striatum to sulfite neurotoxicity in sulfite oxidase-deficient rats. Biochim
Biophys Acta. 2016 Nov;1862(11):2063-2074. doi: 10.1016/j.bbadis.2016.08.007.
Epub 2016 Aug 12. PMID: 27523630.
Veldman A, Santamaria-Araujo JA, Sollazzo S, Pitt J, Gianello R, Yaplito-Lee J,
Wong F, Ramsden CA, Reiss J, Cook I, Fairweather J, Schwarz G. Successful
treatment of molybdenum cofactor deficiency type A with cPMP. Pediatrics. 2010
May;125(5):e1249-54. doi: 10.1542/peds.2009-2192. Epub 2010 Apr 12. PMID:
20385644.
Kocamaz E, Adiguzel E, Er B, Gundogdu G, Kucukatay V. Sulfite leads to neuron
loss in the hippocampus of both normal and SOX-deficient rats. Neurochem Int.
2012 Aug;61(3):341-6. doi: 10.1016/j.neuint.2012.06.010. Epub 2012 Jun 16. PMID:
22709673.
Jakubiczka-Smorag J, Santamaria-Araujo JA, Metz I, Kumar A, Hakroush S, Brueck
W, Schwarz G, Burfeind P, Reiss J, Smorag L. Mouse model for molybdenum cofactor
deficiency type B recapitulates the phenotype observed in molybdenum cofactor
deficient patients. Hum Genet. 2016 Jul;135(7):813-26. doi:
10.1007/s00439-016-1676-4. Epub 2016 May 2. PMID: 27138983.
Theoharides TC, Stewart JM, Panagiotidou S, Melamed I.
Mast cells, brain inflammation and autism. Eur J Pharmacol. 2016 May
5;778:96-102. doi: 10.1016/j.ejphar.2015.03.086. Epub 2015 May 1. PMID:
25941080.
Alam R, Abdolmaleky HM, Zhou JR. Microbiome, inflammation,
epigenetic alterations, and mental diseases. Am J Med Genet B Neuropsychiatr
Genet. 2017 Sep;174(6):651-660. doi: 10.1002/ajmg.b.32567. Epub 2017 Jul 10.
PMID: 28691768.
Doenyas C. Gut Microbiota, Inflammation, and Probiotics on
Neural Development in Autism Spectrum Disorder. Neuroscience. 2018 Mar
15;374:271-286. doi: 10.1016/j.neuroscience.2018.01.060. Epub 2018 Feb 8. PMID:
29427656.
Theoharides TC, Asadi S, Patel AB. Focal brain
inflammation and autism. J Neuroinflammation. 2013 Apr 9;10:46. doi:
10.1186/1742-2094-10-46. PMID: 23570274; PMCID: PMC3626551.
Prata J, Santos SG, Almeida MI, Coelho R, Barbosa MA.
Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and
biomarkers - pre-clinical and clinical investigations. J Neuroinflammation. 2017
Sep 4;14(1):179. doi: 10.1186/s12974-017-0938-y. PMID: 28870209; PMCID:
PMC5584030.
Al-Haddad BJS, Oler E, Armistead B, Elsayed NA, Weinberger
DR, Bernier R, Burd I, Kapur R, Jacobsson B, Wang C, Mysorekar I, Rajagopal L,
Adams Waldorf KM. The fetal origins of mental illness. Am J Obstet Gynecol. 2019
Dec;221(6):549-562. doi: 10.1016/j.ajog.2019.06.013. Epub 2019 Jun 15. PMID:
31207234; PMCID: PMC6889013.
Bjørklund G, Pivina L, Dadar M, Meguid NA, Semenova Y, Anwar M, Chirumbolo S.
Gastrointestinal alterations in autism spectrum disorder: What do we know?
Neurosci Biobehav Rev. 2020 Nov;118:111-120. doi:
10.1016/j.neubiorev.2020.06.033. Epub 2020 Jul 1. PMID: 32621940.
Sears SM, Hewett SJ. Influence of glutamate and GABA transport on brain
excitatory/inhibitory balance. Exp Biol Med (Maywood). 2021
May;246(9):1069-1083. doi: 10.1177/1535370221989263. Epub 2021 Feb 7. PMID:
33554649; PMCID: PMC8113735.
Yang P, Chang CL. Glutamate-mediated signaling and autism spectrum disorders:
emerging treatment targets. Curr Pharm Des. 2014;20(32):5186-93. doi:
10.2174/1381612819666140110120725. PMID: 24410563.
Rojas DC. The role of glutamate and its receptors in autism and the use of
glutamate receptor antagonists in treatment. J Neural Transm (Vienna). 2014
Aug;121(8):891-905. doi: 10.1007/s00702-014-1216-0. Epub 2014 Apr 22. PMID:
24752754; PMCID: PMC4134390.
Kamionkowski S, Shibli F, Ganocy S, Fass R. The relationship between
gastroesophageal reflux disease and autism spectrum disorder in adult patients
in the United States. Neurogastroenterol Motil. 2022 Jul;34(7):e14295. doi:
10.1111/nmo.14295. Epub 2021 Dec 3. PMID: 34859933.
Nath D. Complementary and Alternative Medicine in the School-Age Child With
Autism. J Pediatr Health Care. 2017 May-Jun;31(3):393-397. doi:
10.1016/j.pedhc.2016.12.001. Epub 2016 Dec 22. PMID: 28017488.
Lucarelli J, Pappas D, Welchons L, Augustyn M. Autism Spectrum Disorder and
Avoidant/Restrictive Food Intake Disorder. J Dev Behav Pediatr. 2017
Jan;38(1):79-80. doi: 10.1097/DBP.0000000000000362. PMID: 27824638.
Zhao H, Mao X, Zhu C, Zou X, Peng F, Yang W, Li B, Li G, Ge T, Cui R. GABAergic
System Dysfunction in Autism Spectrum Disorders. Front Cell Dev Biol. 2022 Feb
7;9:781327. doi: 10.3389/fcell.2021.781327. PMID: 35198562; PMCID: PMC8858939.
Yang JQ, Yang CH, Yin BQ. Combined the GABA-A and GABA-B receptor agonists
attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of
autism. Behav Brain Res. 2021 Apr 9;403:113094. doi: 10.1016/j.bbr.2020.113094.
Epub 2021 Jan 29. PMID: 33359845.
Autism | Research | The Florey
Rebutal
EXPERT REACTION: Association between prenatal exposure to plastics and autism in
boys - Scimex
Möhrle D, Wang W, Whitehead SN, Schmid S. GABAB Receptor
Agonist R-Baclofen Reverses Altered Auditory Reactivity and Filtering in the Cntnap2 Knock-Out
Rat. Front Integr Neurosci. 2021 Aug 20;15:710593. doi:
10.3389/fnint.2021.710593. PMID: 34489651; PMCID: PMC8417788.
Canitano R. Mood Stabilizers in Children and Adolescents With Autism Spectrum
Disorders. Clin Neuropharmacol. 2015 Sep-Oct;38(5):177-82. doi:
10.1097/WNF.0000000000000096. PMID: 26366961.
Huang Q, Velthuis H, Pereira AC, Ahmad J, Cooke SF, Ellis CL, Ponteduro FM, Puts
NAJ, Dimitrov M, Batalle D, Wong NML, Kowalewski L, Ivin G, Daly E, Murphy DGM,
McAlonan GM. Exploratory evidence for differences in GABAergic regulation of
auditory processing in autism spectrum disorder. Transl Psychiatry. 2023 Oct
18;13(1):320. doi: 10.1038/s41398-023-02619-8. PMID: 37852957; PMCID:
PMC10584846.
Cai J, Ding L, Zhang JS, Xue J, Wang LZ. Elevated plasma levels of glutamate in
children with autism spectrum disorders. Neuroreport. 2016 Mar 2;27(4):272-6.
doi: 10.1097/WNR.0000000000000532. PMID: 26825346.
Khalifa D, Shahin O, Salem D, Raafat O. Serum glutamate was elevated in children
aged 3-10 years with autism spectrum disorders when they were compared with
controls. Acta Paediatr. 2019 Feb;108(2):295-299. doi: 10.1111/apa.14477. Epub
2018 Jul 16. PMID: 29949195.
Russell-Jones GJ, Ey PL, Reynolds BL. The ability of IgA to inhibit complement
consumption by complement-fixing antigens and antigen-antibody complexes. Aust J
Exp Biol Med Sci. 1984 Feb;62 ( Pt 1):1-10. doi: 10.1038/icb.1984.1. PMID:
6743139.
Russell-Jones GJ, Ey PL, Reynolds BL. Inhibition of cutaneous anaphylaxis and
arthus reactions in the mouse by antigen-specific IgA. Int Arch Allergy Appl
Immunol. 1981;66(3):316-25. doi: 10.1159/000232836. PMID: 6170592.
GcMAF
Therapy for Autism | Saisei Immunotherapy Clinics (saisei-mirai.or.jp)
Copyright © 2014 B12 Oils. All Rights Reserved.
MYTHS
Autism Paradigm
Nemechek
Protocol
Cutler
Chelation Therapy
Toxin
Removal
Vaccine Injured
Elevated Propionic Acid
Cerebral Folate Deficiency
Elevated Glutamate
Inflammation in the Brain in Autism
Photobiomodulation of Epilepsy and Autism
GcMAF therapy and Autism
Autism is due to Genetics
Gastroesophageal Reflux Disease (GERD)
Food Allergen Testing
Gluten Free Diets
Lactose Intolerance, and Dairy Free Diets
Microplastics cause autism
There is no cure for autism
Paradoxical vitamin B12 deficiency
ABA Therapy and SLT
PANS/PANDAS
and Homeopathy
Biofeedback
References
Reproduction in whole or in part in any form or medium without express written
permission is prohibited